About Indexing Sections Topics Subscribe

Journal Awards

Vaccines 2024 Young Investigator Award

Nomination Deadline: 30 November 2024

Eligibility and Requirements:

  • Must have received their PhD no more than 10 years prior to 31 December 2024;
  • Must have produced ground-breaking research and made a significant contribution to the advancement of laboratory and clinical vaccine research, utilization and immunization;
  • Candidates must be nominated by senior scientists.

The Prize:

  • CHF 2000;
  • Option to publish one paper free of charge in Vaccines after peer review before the end of 2025;
  • An electronic certificate.
Read More ❯❯

News Express

Highly Cited Papers in 2022–2023

We warmly invite you to read the highly cited papers of 2022–2023 in Vaccines. These articles come from multiple fields within the scope of Vaccines, and we hope these highly-attractive studies will interest you and bring you new insights. For more information, please visit this link.

Interview with Prof. Mona Mohsen

We interviewed with Prof. Mona Mohsen, the Session Chair of the 2nd International Electronic Conference on Vaccines. Prof. Mona Mohsen expressed his opinions on the ”development status and trends of open access publishing” and “research hotspots in the field of vaccines in the next few years", providing advice on academic research to young scholars in related fields. For more information, please visit this link.

Featured Papers

UL56 Is Essential for Herpes Simplex Virus-1 Virulence In Vivo but Is Dispensable for Induction of Host-Protective Immunity

Nopprarat Tongmuang et al.

B Cells Isolated from Individuals Who Do Not Respond to the HBV Vaccine Are Characterized by Higher DNA Methylation-Estimated Aging Compared to Responders

Katarzyna Malgorzata Kwiatkowska et al.

Read More ❯❯ Read More ❯❯
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge

Pengwei Huang et al.

Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia

Renee Reynolds et al.

Read More ❯❯ Read More ❯❯

To access all papers published in the latest issue, please see here.

Call for Papers

Promoting HPV Vaccination in Diverse Populations

edited by Celia Fisher

submission deadline 31 January 2025

Submit Now ❯❯
Varicella and Zoster Vaccination

edited by Peter Maple

submission deadline 31 January 2025

Submit Now ❯❯